Form 8-K - Current report:
SEC Accession No. 0001437749-23-015525
Filing Date
2023-05-23
Accepted
2023-05-23 07:00:15
Documents
14
Period of Report
2023-05-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20230522_8k.htm   iXBRL 8-K 27253
2 EXHIBIT 99.1 ex_524831.htm EX-99.1 8340
  Complete submission text file 0001437749-23-015525.txt   187564

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20230523.xsd EX-101.SCH 4060
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20230523_def.xml EX-101.DEF 13543
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20230523_lab.xml EX-101.LAB 17733
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20230523_pre.xml EX-101.PRE 13510
8 EXTRACTED XBRL INSTANCE DOCUMENT bcda20230522_8k_htm.xml XML 4331
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 23946496
SIC: 2836 Biological Products, (No Diagnostic Substances)